Professor Chen Ru fu, Vice President of Sun Yat Sen Memorial Hospital, Sun Yat sen University.
Chen Ru fu, male, chief physician, Professor, vice president, doctor of medicine, postdoctoral, doctoral supervisor. He graduated from Tongji Medical University in 1983. He is a doctor of clinical medicine of Zhongshan Medical University.
Languages: English, Putonghua
He graduated from Tongji Medical University in 1983. He is a doctor of clinical medicine of Zhongshan Medical University.
Sun Yat Sen Memorial Hospital, Sun Yat sen University (the Second Affiliated Hospital), vice president, Professor of hepatobiliary surgery, doctoral supervisor, chief physician, director of pancreatic surgery.
- Member of the surgical Committee of international hepatobiliary and pancreatic Chinese branch,
- Member of pancreatic cancer, Chinese Anti Cancer Association,
- Member of spleen surgery group of Chinese Medical Association,
- Vice chairman of surgery branch of Guangdong Medical Association,
- Chairman of minimally invasive surgery committee of Guangdong society of Hepatology,
- Chairman of the pancreatic cancer committee of Guangdong anti cancer association,
- Member of the Standing Committee of surgical branch of Guangdong Medical Association,
- Vice president of Guangdong Medical Equipment Association.
Editorial board members and standing editorial board members of 12 academic journals, including Chinese Journal of surgery, Chinese literature of general surgery, Chinese Journal of clinical surgery, and Chinese Journal of modern oncology. National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation, provincial science and technology research and health department fund evaluation.
Surgical treatment of pancreatic cancer, liver cancer, complex hepatolithiasis, cholangiocarcinoma, portal hypertension and digestive tract tumor; skilled application of minimally invasive technology for bile duct exploration and hepatectomy.
During 27 years of clinical work, he has accumulated rich experience in the diagnosis and surgical treatment of liver, gallbladder, pancreas and spleen diseases. In recent years, the individualized treatment of pancreatic cancer and chronic pancreatitis has been studied deeply. Hepatitis C virus infection was first confirmed to be associated with hilar cholangiocarcinoma at home and abroad, and its carcinogenic mechanism was studied. This research achievement is called one of the most valuable discoveries of biliary surgery in recent years by academician Huang Zhiqiang, founder of modern biliary surgery. Part of this achievement has been adopted by postgraduates and 5-year undergraduate textbooks of surgery.
According to the preoperative imaging data, the "two-step evaluation method" was used to evaluate the resectability, radical resection rate and prognosis of pancreatic cancer and hilar cholangiocarcinoma. It has been recognized by peers at home and abroad.
He has won 3 National Natural Science Foundation projects, 2 national high tech projects (863) and 11 provincial and ministerial level projects, edited 5 surgical monographs, won 3 provincial and ministerial level scientific and technological achievements awards, and published 108 first author's works, 8 of which are included in SCI.